His primary scientific interests are in Angiogenesis, Cell biology, Fibroblast growth factor, Biochemistry and Basic fibroblast growth factor. The study incorporates disciplines such as Endothelial stem cell and Endothelium in addition to Angiogenesis. His Endothelial stem cell study combines topics in areas such as Growth factor and Autocrine signalling.
Marco Rusnati has researched Cell biology in several fields, including Inflammation, PTX3 and Cell growth. His work carried out in the field of Fibroblast growth factor brings together such families of science as Cell, Growth factor receptor inhibitor, Chinese hamster ovary cell and Cancer research. His study in Basic fibroblast growth factor is interdisciplinary in nature, drawing from both Molecular biology, Receptor tyrosine kinase and Chorioallantoic membrane.
Marco Rusnati focuses on Cell biology, Fibroblast growth factor, Angiogenesis, Biochemistry and Basic fibroblast growth factor. Marco Rusnati interconnects Receptor, Integrin and Autocrine signalling in the investigation of issues within Cell biology. His Fibroblast growth factor study combines topics from a wide range of disciplines, such as Cancer research, Growth factor and Endocrinology.
His studies in Angiogenesis integrate themes in fields like Endothelial stem cell and Immunology. Marco Rusnati combines subjects such as Cell growth, Molecular biology, Receptor tyrosine kinase, Plasminogen activator and Cell surface receptor with his study of Basic fibroblast growth factor. Marco Rusnati has included themes like Fibroblast growth factor receptor 3 and Fibroblast growth factor receptor 2 in his Fibroblast growth factor receptor study.
Marco Rusnati mainly investigates Cell biology, Biochemistry, Receptor, Angiogenesis and Fibroblast growth factor. His Cell biology research is multidisciplinary, relying on both Molecular biology, CXC chemokine receptors, Chemokine receptor and Viral matrix protein. His Biochemistry research integrates issues from Immunoglobulin light chain and Antibody.
His Receptor study integrates concerns from other disciplines, such as Amino acid and Mechanism of action. As a part of the same scientific study, Marco Rusnati usually deals with the Angiogenesis, concentrating on Cancer and frequently concerns with Sialic acid, Inflammation and Immunology. Marco Rusnati is interested in Fibroblast growth factor receptor, which is a branch of Fibroblast growth factor.
His main research concerns Fibroblast growth factor, Cell biology, Biochemistry, Angiogenesis and Receptor. Fibroblast growth factor receptor is the focus of his Fibroblast growth factor research. His studies deal with areas such as Tumor progression, Cancer research, Autocrine signalling and Paracrine signalling as well as Fibroblast growth factor receptor.
His Autocrine signalling research focuses on subjects like Molecular biology, which are linked to Infectivity. Marco Rusnati studies Neovascularization, a branch of Angiogenesis. When carried out as part of a general Receptor research project, his work on Growth factor is frequently linked to work in Thrombospondin-2 and Thrombospondins, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Marco Presta;Patrizia Dell’Era;Stefania Mitola;Emanuela Moroni.
Cytokine & Growth Factor Reviews (2005)
Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans
Mudit Tyagi;Marco Rusnati;Marco Presta;Mauro Giacca.
Journal of Biological Chemistry (2001)
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors.
Pascale Jeannin;Barbara Bottazzi;Marina Sironi;Andrea Doni.
Immunity (2005)
Interaction of HIV-1 Tat Protein with Heparin: ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE
Marco Rusnati;Daniela Coltrini;Pasqua Oreste;Giorgio Zoppetti.
Journal of Biological Chemistry (1997)
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
Marco Rusnati;Maura Camozzi;Emanuela Moroni;Barbara Bottazzi.
Blood (2004)
HIV-tat protein is a heparin-binding angiogenic growth factor.
Adriana Albini;Roberto Benelli;Marco Presta;Marco Rusnati.
Oncogene (1996)
Role of the soluble pattern recognition receptor PTX3 in vascular biology.
Marco Presta;Maura Camozzi;Giovanni Salvatori;Marco Rusnati.
Journal of Cellular and Molecular Medicine (2007)
Endogenous Basic Fibroblast Growth Factor Is Implicated in the Vascularization of the Chick Embryo Chorioallantoic Membrane
Domenico Ribatti;Chiara Urbinati;Beatrice Nico;Marco Rusnati.
Developmental Biology (1995)
αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells
Marco Rusnati;Elena Tanghetti;Patrizia Dell’Era;Anna Gualandris.
Molecular Biology of the Cell (1997)
Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
M. Rusnati;M. Presta.
International Journal of Clinical & Laboratory Research (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Brescia
University of Bari Aldo Moro
Humanitas University
University of Milano-Bicocca
King's College London
Humanitas University
University of Siena
University of Turin
KU Leuven
KU Leuven
Fordham University
Pacific Northwest National Laboratory
University of Helsinki
Technical University of Munich
University of Iowa
University of Pisa
University of Glasgow
University of California, Los Angeles
University of Freiburg
Shanghai Jiao Tong University
Bedford Institute of Oceanography
National Institute for Environmental Studies
Medical University of Graz
Erasmus University Rotterdam
University of Toronto
University of Massachusetts Amherst